Search
Search results
VG801 gene therapy shows early promise for Stargardt disease in phase 1/2 clinical trial
VeonGen has reported encouraging early results from a clinical trial of VG801, an investigational gene therapy for Startgardt disease, a genetic retinal condition that currently has no approved treatments.
Information and support
Are you affected by inherited sight loss? We are here to help.
What we do
Our vision is a world where everyone with inherited sight loss is able to live a fulfilling life.
Family planning
If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.
Meet a Researcher: Dr Nikolas Pontikos
Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.
The Kiltwalk 2026 (Dundee)
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.
The Kiltwalk 2026 (Edinburgh)
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.
The Kiltwalk 2026 (Aberdeen)
Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.